Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

13 trials with published results (10%)

Research Maturity

75 completed trials (56% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.2%

7 terminated out of 134 trials

Success Rate

91.5%

+5.0% vs benchmark

Late-Stage Pipeline

8%

11 trials in Phase 3/4

Results Transparency

17%

13 of 75 completed with results

Key Signals

13 with results91% success

Data Visualizations

Phase Distribution

95Total
Not Applicable (55)
Early P 1 (1)
P 1 (11)
P 2 (17)
P 3 (3)
P 4 (8)

Trial Status

Completed75
Unknown22
Recruiting11
Terminated7
Withdrawn6
Not Yet Recruiting5

Trial Success Rate

91.5%

Benchmark: 86.5%

Based on 75 completed trials

Clinical Trials (134)

Showing 20 of 20 trials
NCT06170645Not ApplicableRecruitingPrimary

Transcutaneous Vagus Nerve Stimulation as a Complementary Therapy to Exercise in Chronic Fatigue

NCT07551999Not Yet Recruiting

A Study Of Remote Voice Analysis Tool For Diagnosing And Monitoring ME/CFS

NCT06128967Phase 3Completed

A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial

NCT07256795Not Yet RecruitingPrimary

Blood-Brain Barrier Integrity and Immune Dynamics in Neuropsychiatric Sequelae of Post-SARS-CoV-2 Onset ME/CFS Versus Pre-Pandemic ME/CFS Patients

NCT03844412Phase 2Completed

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

NCT06511050Phase 1Recruiting

Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

NCT04542161Phase 2RecruitingPrimary

Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

NCT03807973Phase 1Suspended

Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.

NCT03759522Phase 1Recruiting

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

NCT04740736Not ApplicableCompleted

Cardiovascular Analysis of PEM

NCT05236465Not ApplicableRecruitingPrimary

A 3-day Course for CFS/ME

NCT00215813UnknownPrimary

Ampligen in Chronic Fatigue Syndrome

NCT06245642Phase 4CompletedPrimary

Compound Ciwujia Granules Treat Chronic Fatigue Syndrome

NCT01071044Phase 4CompletedPrimary

Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome

NCT06585254Not ApplicableRecruiting

tVNS in Long COVID-19

NCT05167227Not ApplicableActive Not Recruiting

Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?

NCT02174003Terminated

Whole Body Hyperthermia Registry Study

NCT05525598Not ApplicableRecruiting

Internet-based Treatment for Patients Suffering From Severe Functional Somatic Disorders

NCT07009691Not ApplicableRecruitingPrimary

Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS

NCT04100915Withdrawn

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in ME/CFS

Scroll to load more

Research Network

Activity Timeline